-
Amoxicillin/clavulanate potassium, did you use it correctly
Time of Update: 2023-01-06
Download the Decision Assistant App and check it anytime, anywhere~References:[1] Chinese Medical Association, Chinese Medical Association Clinical Pharmacy Branch, Chinese Medical Association Journal Society, Chinese Medical Association General Practice Branch, Chinese Medical Association "Chinese Journal of General Practitioners" Editorial Board, Expert Group for Rational Drug Use Guidelines for Primary Medical and Health Institutions.
-
Amoxicillin/clavulanate potassium, did you use it correctly
Time of Update: 2023-01-06
Download the Decision Assistant App and check it anytime, anywhere~References:[1] Chinese Medical Association, Chinese Medical Association Clinical Pharmacy Branch, Chinese Medical Association Journal Society, Chinese Medical Association General Practice Branch, Chinese Medical Association "Chinese Journal of General Practitioners" Editorial Board, Expert Group for Rational Drug Use Guidelines for Primary Medical and Health Institutions.
-
Nigeria implements $12 billion LNG expansion plan
Time of Update: 2022-11-26
Nigeria is joining the United States and Australia in increasing production of the fastest-growing fossil fuels to help meet China's growing demand for the Middle East.
Nigeria is joining the United States and Australia in increasing production of the fastest-growing fossil fuels to help meet China's growing demand for the Middle East.
-
Issue 4/2014 - Clariant provides flame retardant protection for renewable thermoplastic composites
Time of Update: 2022-11-12
(Cold swimming) Clariant provides flame retardant protection for renewable thermoplastic composites A study conducted by the Materials and Conversion Research Unit (UMET) at the University of Lille in France showed that the use of Clariant's Exolit AP halogen-free flame retardant can achieve highly efficient flame retardant of oyster shell reinforced polypropylene (PP).
-
Hand in hand, empowering innovation, Thermo Flying to the "Appointment of the Expo
Time of Update: 2022-10-25
Shanghai, October 20, 2022 – The closely watched 5th China International Import Expo (CIIE) is about to officially kick off. Thermo Fisher Scientific (hereinafter referred to as Thermo Fisher Fisher
-
Birch Webinar: Latest Developments in Cutting-Edge Technology in High-Throughput Drug Development
Time of Update: 2022-09-14
cn Hong Kong Beijing Shanghai Guangzhou Chengdu Jinan BioAuxilium Enhanced Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Technology – THUNDER™ biomarker detection is designed to enable simple, fast, sensitive and reliable quantification of intracellular and intracellular supernatant biomarkers, ideal for cell signaling and cytokine analysis, with significant advantages over traditional ELISA: homogeneous, low sample size, one-step method, wider dynamic range, high throughput, stability and reproducibility.
-
Improvement of myocardial hypertrophy in high altitude environment with probiotics
Time of Update: 2022-04-15
This shows that probiotic preparations can effectively regulate the intestinal flora, promote the homeostasis of metabolites, and have a significant inhibitory effect on myocardial hypertrophy under high altitude hypoxia, thereby reducing potential risks such as heart failure The exploration and clinical trials of altitude sickness in regional populations have laid a scientific foundation .
-
Important breakthrough
Time of Update: 2022-03-09
"Fig. 1 GLP1R is expressed in human carotid bodyFig. 2 GLP1R regulates sympathetic nerve activityFig. 3 Activation of GLP1R inhibits chemoreflex-induced arterial blood pressure response"GLP1-CBs pathway" may become a new target for diabetes-hypertension therapy" People with high blood pressure and/or diabetes are at high risk for life-threatening cardiovascular disease .
-
Phase III Registration Clinical Study of KN046 Combined with Chemotherapy for Advanced Pancreatic Cancer Completes First Patient DosingPress Release
Time of Update: 2022-03-08
HK) announced that PD-L1/CTLA-4 dual anti-KN046 combined with nab-paclitaxel and gemcitabine in the first-line treatment of advanced pancreatic cancer Phase III Registered clinical study (study number: KN046-303, ENREACH-PANCREATIC-01) completed the first patient dosing .
-
Express mRNA vaccine opens up new battlefield again to challenge latent virus
Time of Update: 2022-01-27
Today, BioNTech/Pfizer, and Moderna respectively announced new progress in the development of infectious disease vaccines .
de/news-releases/news-release -details/pfizer-and-biontech-sign-new-global-collaboration-agreement[2] MODERNA ANNOUNCES FIRST PARTICIPANT DOSED IN PHASE 1 STUDY OF ITS MRNA EPSTEIN-BARR VIRUS (EBV) VACCINE.
-
"CCTV News" Zhaotong Where can I still buy a driver's license now "Mobile Sohu.com" Y
Time of Update: 2021-11-02
"CCTV News" Zhaotong, where can I still buy a driver’s license now "Mobile Sohu" plus satellite [11231939] I hope to help you a few days ago, I always get a test but I just ask a friend to introduce a
-
"CCTV News" Where can I buy a driver's license in Xuzhou "Mobile Sohu.com" N
Time of Update: 2021-11-02
Zhongyou Express subsequently changed its name to Jingxi Express and merged into the Jingxi business group .
According to a public post joined by ▲ Chen Zhengping, Ranger of Danzhou Bay Before 2010, Chen Zhengping was a boss in a seafood business and he used to grow up!
-
Positive results of Agenus anti-PD-1 monoclonal antibody for treatment of refractory cervical cancer stage 2
Time of Update: 2021-10-11
On August 26, 2021, Agenus announced that its anti-PD-1 monoclonal antibody batilimumab (balstilimab), a single-drug treatment of recurrent/metastatic cervical cancer, was published online in the international peer-reviewed journal.
-
Mori Kylin establishes a Spanish subsidiary
Time of Update: 2021-08-27
issued an announcement that in order to further promote the internationalization strategy, the company intends to use its own funds to establish overseas investment in Spain by its wholly-owned subsidiary Senkirin (Hong Kong) Trading Co.
-
Sartorius's performance in the first half of the year has grown rapidly and its annual forecast is raised again
Time of Update: 2021-07-28
" Group business development At a constant exchange rate, the group's sales revenue increased by 60.
0% at a constant exchange rate in the first half of 2021, reaching 363 million euros (report: +46.